Trade Summary

3 days ago, Boughton Soleil, serving as GC at Hims & Hers Health, Inc. (HIMS), sold 9,463 shares at $30.00 per share, for a total transaction value of $283,890.00. Following this transaction, Boughton Soleil now holds 299,368 shares of HIMS.

This sale represents a 3.00% decrease in Boughton Soleil's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, April 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 22, 2026, 2 days after the trade was made.

Hims & Hers Health, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.